-
2017 Federal Budget Increases Research Funding
May 3, 2017
… Update: The president signed the FY 2017 budget proposal into law on May 5, 2017. Earlier this week, Congress … year, the deal includes increased investments in federal research funding, which is a win for the Parkinson's … budget deal impacting the government agencies involved in research and drug development. The PD community has actively …
-
News in Context: Early Positive Results of Electrical Spinal Stimulation for Parkinson’s Patients
November 9, 2023
… A global team of researchers captured the attention of the scientific world … Parkinson’s disease (PD). The scientists implanted a device into a 62-year-old Parkinson’s patient who has lived with PD … plans to fund even more research on the subject in early 2024, as the GALOP committee advises on awards for our …
-
Forbes: A Paradigm Shift For Medical Research
May 7, 2007
… Yet when it comes to the vast enterprise of biomedical research, there's room to question how well the system we've … illness or injury? Over $100 billion is spent on biomedical research each year. Roughly a third of that money goes … are strategically allocated to converting basic discoveries into truly new therapies. This is a higher-risk and …
-
Four New RFAs Span Our Research Priorities
March 4, 2020
… For additional information, review our FAQs on COVID-19 and research support. The Michael J. Fox Foundation (MJFF) is … measure and treat Parkinson’s. These programs are open to researchers in non- and for-profit organizations both within … (1) developing therapeutics for non-motor symptoms and (2) early drug discovery for novel targets with few or no …
-
Fox Insight Brings Research to You, at Home
June 4, 2020
… in 2000, he had a vision to bring people living with PD and researchers together into a two-way dialogue. Today, nearly 50,000 people — with and without Parkinson’s disease — …
-
Investor & Industry Resources to De-Risk Parkinson’s Research
… MJFF is expediting Parkinson’s disease research, working tirelessly to advance global opportunities … the therapeutic and biomarker landscape—offering insights into emerging science, development progress, and MJFF’s role … MJFF is committed to supporting efforts that de-risk early-stage Parkinson's disease research to accelerate …